Withaferin A affects the expression of 4 different genes (CD47, CENPB, PAQR4, SLC44A1) that, in turn, affect the survival plots in patients with uterine corpus endometrial carcinoma (CD47), brain lower-grade glioma (CENPB), kidney renal clear cell carcinoma (PAQR4), kidney renal papillary cell carcinoma (PAQR4), liver hepatocellular carcinoma (PAQR4) and pancreatic adenocarcinoma (SLC44A1) (Table 1). This evidence concerns the gene CD47 and pancreatic adenocarcinoma.